Institutional Ownership Entrada Therapeutics, Inc. (TRDA)
This table provides information about the institutional ownership of Entrada Therapeutics, Inc. (TRDA). We have compiled data on the 117 institutions that hold shares in the stock, with a total of 27.9 Million shares, which have been reported (via 13F filing form) to have a value of $237 Million.
| Holding | Report Date | shares Held | Holding Value (Reported) | Last Trade | Trade History |
|---|---|---|---|---|---|
|
Baker Bros. Advisors LP
New York, NY |
Nov 14, 2025 Q3 2025 |
4,865,819
shares
|
$41.2 Million
0.23% of portfolio
|
Q2 2022
Added 3.43%
|
|
|
Mpm Asset Management LLC
Cambridge, MA |
Nov 14, 2025 Q3 2025 |
4,381,062
shares
|
$37.1 Million
56.82% of portfolio
|
Q4 2024
Reduced 1.01%
|
|
|
5 Am Venture Management, LLC
San Francisco, CA |
Nov 14, 2025 Q3 2025 |
4,256,379
shares
|
$36.1 Million
16.56% of portfolio
|
Q3 2025
Reduced 1.21%
|
|
|
Black Rock Inc.
New York, NY |
Aug 13, 2024 Q2 2024 |
1,693,867
shares
|
$14.3 Million
0.0% of portfolio
|
Q2 2024
Added 13.98%
|
|
|
Vanguard Group Inc
Valley Forge, PA |
Nov 07, 2025 Q3 2025 |
1,604,225
shares
|
$13.6 Million
0.0% of portfolio
|
Q3 2025
Reduced 0.04%
|
|
|
Wellington Management Group LLP
Boston, MA |
Nov 14, 2025 Q3 2025 |
954,419
shares
|
$8.08 Million
0.0% of portfolio
|
Q3 2025
Reduced 10.02%
|
|
|
Israel Englander
Millennium Management LLC | New York, Ny
|
Nov 14, 2025 Q3 2025 |
836,609
shares
|
$7.09 Million
0.0% of portfolio
|
Q3 2025
Added 391.19%
|
|
|
Step Stone Group LP
La Jolla, CA |
Nov 14, 2025 Q3 2025 |
761,277
shares
|
$6.45 Million
13.01% of portfolio
|
Q3 2022
Added 19.89%
|
|
|
Geode Capital Management, LLC
Boston, MA |
Nov 12, 2025 Q3 2025 |
645,119
shares
|
$5.46 Million
0.0% of portfolio
|
Q3 2025
Added 2.15%
|
|
|
Jim Simons
Renaissance Technologies LLC | New York, Ny
|
Nov 13, 2025 Q3 2025 |
594,300
shares
|
$5.03 Million
0.0% of portfolio
|
Q3 2025
Added 56.6%
|
|
|
Tcg Crossover Management, LLC
Palo Alto, CA |
Nov 14, 2025 Q3 2025 |
584,955
shares
|
$4.95 Million
0.38% of portfolio
|
Q4 2022
Reduced 8.91%
|
|
|
State Street Corp
Boston, MA |
Nov 14, 2025 Q3 2025 |
498,615
shares
|
$4.22 Million
0.0% of portfolio
|
Q3 2025
Added 0.56%
|
|
|
Dimensional Fund Advisors LP
Austin, TX |
Nov 12, 2025 Q3 2025 |
394,279
shares
|
$3.34 Million
0.0% of portfolio
|
Q3 2025
Reduced 7.01%
|
|
|
Price T Rowe Associates Inc
Baltimore, MD |
Nov 14, 2025 Q3 2025 |
360,526
shares
|
$3.05 Million
0.0% of portfolio
|
Q3 2025
Reduced 85.96%
|
|
|
Morgan Stanley
New York, NY |
Nov 14, 2025 Q3 2025 |
346,756
shares
|
$2.94 Million
0.0% of portfolio
|
Q3 2025
Added 112.61%
|
|
|
Royce & Associates LP
|
Nov 12, 2025 Q3 2025 |
345,507
shares
|
$2.93 Million
0.02% of portfolio
|
Q3 2025
Added 54.76%
|
|
|
Ken Griffin
Citadel Advisors LLC | Chicago, Il
|
Nov 14, 2025 Q3 2025 |
335,741
shares
|
$2.84 Million
0.0% of portfolio
|
Q3 2025
Added 234.55%
|
|
|
Jacobs Levy Equity Management, Inc
Florham Park, NJ |
Nov 17, 2025 Q3 2025 |
315,810
shares
|
$2.67 Million
0.01% of portfolio
|
Q3 2025
Added 43.07%
|
|
|
Acadian Asset Management LLC
Boston, MA |
Nov 13, 2025 Q3 2025 |
297,943
shares
|
$2.52 Million
0.0% of portfolio
|
Q3 2025
Added 550.45%
|
|
|
Qube Research & Technologies LTD
London, X0 |
Nov 14, 2025 Q3 2025 |
287,873
shares
|
$2.44 Million
0.0% of portfolio
|
Q3 2025
Added 115.26%
|
|
|
Northern Trust Corp
Chicago, IL |
Nov 14, 2025 Q3 2025 |
253,607
shares
|
$2.15 Million
0.0% of portfolio
|
Q3 2025
Reduced 15.55%
|
|
|
Jane Street Group, LLC
New York, NY |
Nov 13, 2025 Q3 2025 |
247,516
shares
|
$2.1 Million
0.0% of portfolio
|
Q3 2025
Added 383.83%
|
|
|
Goldman Sachs Group Inc
New York, NY |
Nov 14, 2025 Q3 2025 |
222,336
shares
|
$1.88 Million
0.0% of portfolio
|
Q3 2025
Added 164.21%
|
|
|
Charles Schwab Investment Management Inc
San Francisco, CA |
Nov 10, 2025 Q3 2025 |
185,259
shares
|
$1.57 Million
0.0% of portfolio
|
Q3 2025
Reduced 9.05%
|
|
|
Jpmorgan Chase & CO
New York, NY |
Nov 26, 2025 Q3 2025 |
133,878
shares
|
$1.13 Million
0.0% of portfolio
|
Q3 2025
Added 810.36%
|
|